Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
280 participants
INTERVENTIONAL
2007-12-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Establishing Safe Drainage Limits for Pleural Chest Tube Removal.
NCT00574002
Evaluation of Fluid Output Threshold for Safe Chest Tube Removal - A Potential Way to Decrease Length of Stay in Hospital and to Improve Postoperative Care After Lung Surgery?
NCT03093610
Chest Tube Drainage of Transudative Pleural Effusions Hastens Liberation From Mechanical Ventilation
NCT01104285
Clinical Trial Evaluating the Optimal Technique for Chest Tube Removal
NCT00873587
Negative Pleural Suction for Tube Thoracostomy in Patients With Chest Trauma
NCT01864577
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Thoracostomy tube management practices, including the drainage volume threshold used, may be dissimilar for different types of disease processes, so this study will be restricted to patients who required a thoracostomy tube for treatment of traumatic injury.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
No drainage threshold
No drainage threshold
Removal of the thoracostomy tube independently of the amount of fluid that drained from the tube in the prior 24 hours
2
Drainage \<2 mL/kg
Drainage <2 mL/kg
Removal of the thoracostomy tube only if the drainage from the tube in the prior 24 hours is less than 2 mL/kg of the patient's ideal body weight
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No drainage threshold
Removal of the thoracostomy tube independently of the amount of fluid that drained from the tube in the prior 24 hours
Drainage <2 mL/kg
Removal of the thoracostomy tube only if the drainage from the tube in the prior 24 hours is less than 2 mL/kg of the patient's ideal body weight
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age at least 14 years
* Hospitalized for traumatic injury or elective operation
Exclusion Criteria
* Mediastinal tubes
* Death expected within 48 hours
* Prisoner status
* Severe congestive heart failure
* End-stage liver disease
* End-stage renal disease
* History of or suspected empyema involving the pleural cavity of interest
* History of or anticipated need for pleurodesis of the pleural cavity of interest
* Malignant pleural effusion
* Pregnancy
* Previous participation in this study
* Thoracostomy tube drainage already \<2 mL/kg
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Garth H Utter, MD MSc
Role: PRINCIPAL_INVESTIGATOR
University of California, Davis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Davis, Medical Center
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200715709
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.